NALUZOTAN

Search structure
Synonyms:
Status: Phase 3
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: LQ54E5B4EW

Structure
InChI Key SPWZXWDPAWDKQE-UHFFFAOYSA-N
Smile CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1
InChI
InChI=1S/C23H38N4O3S/c1-20(28)25-22-10-7-11-23(18-22)27-16-14-26(15-17-27)13-6-5-12-24-31(29,30)19-21-8-3-2-4-9-21/h7,10-11,18,21,24H,2-6,8-9,12-17,19H2,1H3,(H,25,28)

Physicochemical Descriptors

Property Name Value
Molecular Formula C23H38N4O3S
Molecular Weight 450.65
AlogP 3.05
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 10.0
Polar Surface Area 81.75
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 31.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Serotonin 1a (5-HT1a) receptor agonist PubMed Wikipedia
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Ion channel Voltage-gated ion channel Potassium channels Voltage-gated potassium channel
- 3800-3800 - - 21
Membrane receptor Family A G protein-coupled receptor Small molecule receptor (family A GPCR) Monoamine receptor Adrenergic receptor
- - - 1600 -
Membrane receptor Family A G protein-coupled receptor Small molecule receptor (family A GPCR) Monoamine receptor Serotonin receptor
20-93 - - 17-30 -
Membrane receptor
20-93 - - 17-30 -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Anxiety 3 D001007 ClinicalTrials
Epilepsy, Temporal Lobe 2 D004833 ClinicalTrials
Depressive Disorder, Major 2 D003865 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL209821
DrugBank DB05562
FDA SRS LQ54E5B4EW
PubChem 11430856
SureChEMBL SCHEMBL678016
ZINC ZINC000003963096
CONTENTS